Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Industrial Manufacturing
Industrial Products
2,115 Cr
Moderate Risk
21.5
44.3
0.1
2.7
666.00
327.35
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
4
Neutral
2
Bullish
8
Bearish
28
Neutral
10
Bullish
8
Bearish
24
Neutral
8
Bullish
0
Bearish
4
Neutral
2
Bullish
8
Bearish
4
Neutral
2
Bullish
8
Bearish
24
Neutral
8
Bullish
0
Bearish
24
Neutral
8
Bullish
0
Bearish
24
Neutral
8
Bullish
0
GSP Crop Science Ltd (GSPCROP) is currently trading at 434.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
GSP Crop Science Limited is an integrated agrochemical company that develops, manufactures and sells technical-grade active ingredients and crop-protection formulations across domestic B2C, domestic B2B and export markets, with manufacturing sites in Gujarat, Nandesari, Dahej, Saykha and a Brazil subsidiary to service Latin America. Q1 FY27 revenue was INR 386 crore with PAT of INR 26.4 crore and reported EBITDA near 11%; management cites improved gross margins driven by a higher mix of patented and differentiated formulations and a one-off other income item from a land sale boosting P&L in the quarter. The company operates a multi-channel model (domestic B2C ~45%, domestic B2B ~45%, exports ~10% in Q1) and targets doubling the share of patented products within branded B2C over three years, leveraging a portfolio of over 200 domestic products, 175+ export formulations and more than 100 granted patents. GSP is pursuing backward integration and R&D-led product introductions to mitigate raw-material volatility, with technical capacity utilisation at ~70–75% and formulation utilisation at ~25–30%, indicating headroom to absorb higher-value, low-volume molecules without immediate major capex. Strategically, the company aims for ~15% CAGR in revenue over the medium term, margin expansion via product-mix shift and continuing deleveraging after IPO-funded debt repayment; credit rating was upgraded to A+ reflecting improved leverage and liquidity management.
Over the past 52 weeks, GSP Crop Science Ltd has traded between a low of ₹327.35 and a high of ₹666.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
GSP Crop Science Ltd has a market capitalization of approximately 2,115.21. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
GSP Crop Science Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 2,115.21 Cr, GSP Crop Science Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
GSP Crop Science Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of GSP Crop Science Ltd is 21.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board approved the unaudited financial results for Q3 and the nine months ended December 31, 2025. It also approved the sale of 66,740.60 sq. meters of industrial land to a promoter group company for ₹23.65 crore.
The total IPO size is ₹400 crore. This includes a fresh issue of shares worth ₹240 crore and an Offer for Sale (OFS) of shares valued at ₹160 crore by existing promoters.
The IPO will be open for public subscription from March 16 to March 18, 2026.